• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从行政索赔中诊断糖尿病,并估计威尼托地区(意大利东北部)420 万人中糖尿病的真实患病率。

Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy).

机构信息

Department of Information Engineering, University of Padova, Padova, Italy.

Arsenàl.IT, Veneto's Research Centre for eHealth Innovation, Treviso, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):84-91. doi: 10.1016/j.numecd.2019.08.017. Epub 2019 Sep 9.

DOI:10.1016/j.numecd.2019.08.017
PMID:31757572
Abstract

BACKGROUND AND AIMS

Diabetes can often remain undiagnosed or unregistered in administrative databases long after its onset, even when laboratory test results meet diagnostic criteria. In the present work, we analyse healthcare data of the Veneto Region, North East Italy, with the aims of: (i) developing an algorithm for the identification of diabetes from administrative claims (4,236,007 citizens), (ii) assessing its reliability by comparing its performance with the gold standard clinical diagnosis from a clinical database (7525 patients), (iii) combining the algorithm and the laboratory data of the regional Health Information Exchange (rHIE) system (543,520 subjects) to identify undiagnosed diabetes, and (iv) providing a credible estimate of the true prevalence of diabetes in Veneto.

METHODS AND RESULTS

The proposed algorithm for the identification of diabetes was fed by administrative data related to drug dispensations, outpatient visits, and hospitalisations. Evaluated against a clinical database, the algorithm achieved 95.7% sensitivity, 87.9% specificity, and 97.6% precision. To identify possible cases of undiagnosed diabetes, we applied standard diagnostic criteria to the laboratory test results of the subjects who, according to the algorithm, had no diabetes-related claims. Using a simplified probabilistic model, we corrected our claims-based estimate of known diabetes (6.17% prevalence; 261,303 cases) to account for undiagnosed cases, yielding an estimated total prevalence of 7.50%.

CONCLUSION

We herein validated an algorithm for the diagnosis of diabetes using administrative claims against the clinical diagnosis. Together with rHIE laboratory data, this allowed to identify possibly undiagnosed diabetes and estimate the true prevalence of diabetes in Veneto.

摘要

背景与目的

糖尿病在发病后很长时间内,即使实验室检查结果符合诊断标准,也常常在行政数据库中未被诊断或未被登记。在本研究中,我们分析了意大利东北部威尼托地区的医疗保健数据,旨在:(i) 从行政索赔中(4,236,007 名公民)开发一种用于识别糖尿病的算法;(ii) 通过与临床数据库(7525 名患者)中的金标准临床诊断比较来评估其可靠性;(iii) 将算法与区域健康信息交换(rHIE)系统的实验室数据相结合,以识别未确诊的糖尿病;(iv) 提供威尼托地区糖尿病真实患病率的可信估计。

方法与结果

用于识别糖尿病的算法由与药物配给、门诊就诊和住院相关的行政数据提供。该算法与临床数据库评估的结果为,敏感性为 95.7%,特异性为 87.9%,准确性为 97.6%。为了识别可能的未确诊糖尿病病例,我们将标准诊断标准应用于根据算法没有糖尿病相关索赔的受试者的实验室检查结果。使用简化的概率模型,我们校正了基于索赔的已知糖尿病(6.17%的患病率;261,303 例)估计值,以考虑未确诊病例,估计总患病率为 7.50%。

结论

我们使用行政索赔对临床诊断验证了一种用于诊断糖尿病的算法。与 rHIE 实验室数据结合使用,可以识别可能未被诊断的糖尿病,并估计威尼托地区糖尿病的真实患病率。

相似文献

1
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy).从行政索赔中诊断糖尿病,并估计威尼托地区(意大利东北部)420 万人中糖尿病的真实患病率。
Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):84-91. doi: 10.1016/j.numecd.2019.08.017. Epub 2019 Sep 9.
2
Detecting Undiagnosed Diabetes: Proof-of-Concept Based on the Health-Information Exchange System of the Veneto Region (North-East Italy).
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:4293-4296. doi: 10.1109/EMBC.2019.8857608.
3
Can administrative health utilisation data provide an accurate diabetes prevalence estimate for a geographical region?行政健康利用数据能否为一个地理区域提供准确的糖尿病患病率估计?
Diabetes Res Clin Pract. 2018 May;139:59-71. doi: 10.1016/j.diabres.2018.02.028. Epub 2018 Feb 24.
4
Identification of prevalent patients with epilepsy using administrative data: the Tuscany experience.利用行政数据识别癫痫流行患者:托斯卡纳的经验。
Neurol Sci. 2017 Apr;38(4):571-577. doi: 10.1007/s10072-016-2798-0. Epub 2017 Jan 4.
5
Prevalence of chronic kidney disease in the Lazio region, Italy: a classification algorithm based on health information systems.意大利拉齐奥地区慢性肾脏病的患病率:基于健康信息系统的分类算法。
BMC Nephrol. 2020 Jan 28;21(1):23. doi: 10.1186/s12882-020-1689-z.
6
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.使用行政数据库通过一项基于人群的纵向研究估算糖尿病负担。
PLoS One. 2014 Dec 3;9(12):e113741. doi: 10.1371/journal.pone.0113741. eCollection 2014.
7
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey.VALORE 项目中意大利行政数据库的慢性病患病率:通过与全科医生数据库和全国调查的人群估计值进行比较来验证。
BMC Public Health. 2013 Jan 9;13:15. doi: 10.1186/1471-2458-13-15.
8
Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.意大利北部某地区糖尿病的流行病学趋势及直接成本:2012年健康管理记录分析,《LHT》第20期,维罗纳。
Prim Care Diabetes. 2017 Dec;11(6):570-576. doi: 10.1016/j.pcd.2017.06.001. Epub 2017 Jun 27.
9
Incidence of diabetes mellitus in Italy in year 2018. A nationwide population-based study of the ARNO Diabetes Observatory.2018 年意大利的糖尿病发病率。ARNO 糖尿病观察站的一项全国性基于人群的研究。
Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2338-2344. doi: 10.1016/j.numecd.2021.04.017. Epub 2021 May 3.
10
Novel screening metric for the identification of at-risk peripheral artery disease patients using administrative claims data.利用行政索赔数据识别外周动脉疾病高危患者的新型筛查指标。
Vasc Med. 2016 Feb;21(1):33-40. doi: 10.1177/1358863X15616687. Epub 2015 Nov 24.

引用本文的文献

1
Social inequalities in diabetes incidence and quality of care: results from a cohort study in the Lazio region, Italy.糖尿病发病率和护理质量方面的社会不平等:意大利拉齐奥地区一项队列研究的结果
BMJ Open. 2025 Jul 17;15(7):e091738. doi: 10.1136/bmjopen-2024-091738.
2
Developmental Impacts of Epigenetics and Metabolism in COVID-19.表观遗传学与新陈代谢在新冠病毒病中的发育影响
J Dev Biol. 2024 Feb 9;12(1):9. doi: 10.3390/jdb12010009.
3
Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects.血糖控制可预测糖尿病患者的 SARS-CoV-2 预后。
Acta Diabetol. 2023 Jun;60(6):817-825. doi: 10.1007/s00592-023-02073-4. Epub 2023 Mar 20.
4
COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management.巴基斯坦糖尿病癌症患者中的新冠肺炎:临床特征与管理
Front Oncol. 2022 Aug 18;12:922579. doi: 10.3389/fonc.2022.922579. eCollection 2022.
5
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis.基于循环神经网络的 2 型糖尿病降糖药物与心血管结局的时变轨迹分析。
Cardiovasc Diabetol. 2022 Aug 22;21(1):159. doi: 10.1186/s12933-022-01600-x.
6
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims.使用行政索赔数据,在不同护理环境下评估心力衰竭住院风险评分在 2 型糖尿病中的表现。
Sci Rep. 2022 May 11;12(1):7762. doi: 10.1038/s41598-022-11758-9.
7
Diabetes Mellitus Diagnosis and Screening in Australian General Practice: A National Study.澳大利亚全科医学中的糖尿病诊断和筛查:一项全国性研究。
J Diabetes Res. 2022 Mar 23;2022:1566408. doi: 10.1155/2022/1566408. eCollection 2022.
8
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study.GLP-1 受体激动剂或基础胰岛素起始常规治疗 2 型糖尿病的心血管结局:一项区域范围的回顾性研究。
Cardiovasc Diabetol. 2021 Nov 13;20(1):222. doi: 10.1186/s12933-021-01414-3.
9
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.改善他汀类药物治疗策略以降低 LDL 胆固醇:2 型糖尿病患者和非 2 型糖尿病患者达标相关因素。
Cardiovasc Diabetol. 2021 Jul 16;20(1):144. doi: 10.1186/s12933-021-01338-y.
10
[Diabetes and COVID-19].[糖尿病与2019冠状病毒病]
Therapie. 2020 Apr 23. doi: 10.1016/j.therap.2020.04.004.